Stopper with low force for use in an injector
11660398 · 2023-05-30
Assignee
Inventors
Cpc classification
A61M5/31513
HUMAN NECESSITIES
International classification
Abstract
The present invention relates to a stopper for an injector for delivery of a pharmaceutical composition and to an injector with the stopper. The stopper has a stopper body with an actuating surface opposite an outlet surface, an axial length between the actuating surface and the outlet surface, and a transverse diameter, which stopper body defines an access diameter, the stopper at an axial location from the actuating surface comprising a deformable sealing element surrounding the stopper body and having an outer diameter, which is larger than the transverse diameter, which deformable sealing element is made from a thermoplastic elastomer and has an axial extension in the range of 5% and 95% of the axial length of the stopper body, and the stopper comprising a cavity at the axial location of the deformable sealing element, the cavity having a lateral extension larger than the access diameter of the stopper body.
Claims
1. An injector for delivery of a pharmaceutical composition, the injector comprising a cylinder having an inner wall, a piston rod, and a stopper having a stopper body with an actuating surface opposite an outlet surface, an axial length between the actuating surface and the outlet surface, and a transverse diameter, the stopper body having a tubular section having an access diameter, the stopper at an axial location from the actuating surface comprising a deformable sealing element made from a thermoplastic elastomer (TPE), which deformable sealing element surrounds the stopper body, has an outer diameter, which is larger than the transverse diameter, and a deformable sealing element axial extension in the range of 5% and 95% of the axial length of the stopper body, which deformable sealing element seals an annular gap between the stopper body and the inner wall of the cylinder, and the stopper comprising a cavity at the axial location of the deformable sealing element, the cavity comprising a compressible fluid and having a lateral extension larger than the access diameter and at least 50% of the outer diameter of the deformable sealing element and a cavity axial extension in the range of 5% to 50% of the axial length of the stopper body, and which cavity is formed at an interface between the stopper body and the piston rod and/or at an interface between the deformable sealing element and the piston rod.
2. The injector according to claim 1, wherein the cavity axial extension is in the range of 10% to 50% of the axial length of the stopper body.
3. The injector according to claim 1, wherein the cavity has a cylindrical, an ellipsoidal or a toroidal shape.
4. The injector according to claim 1, wherein the stopper body comprises an actuating stopper element and an outlet stopper element each comprising a deformable sealing element as defined in claim 1, which actuating stopper element and which outlet stopper element are linked together by a resilient frame, the outlet stopper element being located at a first axial location from the actuating surface, and the actuating stopper element being located at a second axial location from the actuating surface, the stopper having the cavity at the first axial location.
5. The injector according to claim 4, wherein the stopper comprises a second cavity at the second axial location.
6. The injector according to claim 4, wherein the resilient frame has a cylindrical shape.
7. The injector according to claim 1, wherein the deformable sealing element is an O-ring with a recess along the inner diameter of the O-ring so that upon mounting of the O-ring on the stopper body or the piston rod the cavity is formed between the O-ring and the stopper body or between the O-ring and the piston rod at the recess of the O-ring.
8. The injector according to claim 1, wherein the stopper body has a cylindrical shape and the deformable sealing element is comprised on a cylindrical structure for mounting on the stopper body or the piston rod, so that upon mounting of the cylindrical structure on the stopper body or the piston rod, the cavity is formed between the stopper body or the piston rod and the cylindrical structure.
9. The injector according to claim 1, wherein the deformable sealing element has or the stopper body and the deformable sealing element have a Shore A hardness in the range of 30 to 90.
10. The injector according to claim 1, wherein the stopper body is made from a TPE.
11. The injector according to claim 1, wherein the deformable sealing element is at a first axial location from the actuating surface and a cavity at the first axial location and wherein the stopper further comprises a second deformable sealing element at a second axial location from the actuating surface and a second cavity at the second axial location.
12. The injector according to claim 1, wherein the deformable sealing element is at a first axial location from the actuating surface and wherein the stopper further comprises a second deformable sealing element at a second axial location from the actuating surface and the cavity extends between the first axial location and the second axial location.
13. The injector according to claim 1, wherein the outer diameter of the deformable sealing element is in the range of 1.5% to 10% larger than the inner diameter of the cylinder before inserting the stopper into the cylinder.
14. The injector according to claim 1, wherein the deformable sealing element has a Shore A hardness in the range of 30 to 90, and wherein the injector does not comprise an external lubricant.
15. The injector according to claim 1, wherein the cylinder is made from glass.
16. The injector according to claim 1, wherein the cylinder has an inner diameter in the range of 2 mm to 12 mm.
17. The injector according to claim 1, wherein the cylinder is prefilled with a pharmaceutical composition.
18. The injector according to claim 1, wherein the deformable sealing element is convex and the deformable sealing element axial extension is in the range of 5% to 25% of the axial length of the stopper body.
19. The injector according to claim 1, wherein the stopper body has a diameter in the range of 50% to 90% of the outer diameter of the deformable sealing element.
20. The injector according to claim 1, wherein the deformable sealing element is convex and is further defined by an angle between the stopper body and the deformable sealing element, which angle is the range of 120° to 160°.
21. The injector according to claim 1, wherein the deformable sealing element is convex and an actuating contact angle facing the actuating surface of the stopper is formed between the inner wall of the cylinder and the deformable sealing element, which actuating contact angle is in the range of 5° to 60°.
22. The injector according to claim 1, wherein the deformable sealing element is convex and an outlet contact angle facing the outlet surface of the stopper is formed between the inner wall of the cylinder and the deformable sealing element, which outlet contact angle is in the range of 5° to 60°.
23. The injector according to claim 1, wherein the deformable sealing element is convex and an actuating contact angle facing the actuating surface of the stopper is formed between the inner wall of the cylinder and the deformable sealing element, and an outlet contact angle facing the outlet surface of the stopper is formed between the inner wall of the cylinder and the deformable sealing element, which actuating contact angle and outlet contact angle are independently in the range of 5° to 60°.
Description
BRIEF DESCRIPTION OF THE FIGURES
(1) In the following the invention will be explained in greater detail with the aid of examples and with reference to the schematic drawings, in which
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
(15)
(16)
(17)
(18)
(19) It should be understood that combinations of the features in the various embodiments are also contemplated, and that the various features, details and embodiments may be combined into other embodiments.
(20) Reference to the figures serves to explain the invention and should not be construed as limiting the features to the specific embodiments as depicted.
DETAILED DESCRIPTION OF THE INVENTION
(21) The present invention relates to stoppers for injectors for delivery of a pharmaceutical composition and to injectors. The present invention will now be described in greater detail with reference to the appended drawings. Certain figures are depicted as “cross-sectional views” of the injectors of the invention, where the injector in the “cross-sectional view” is depicted at an angle of 90° compared to the injector otherwise depicted. Certain figures depict side views of injectors of the invention. These side views do not depict the outlet of the injectors but it is to be understood that the injector of the invention will have an outlet, e.g. fitted with a hypodermic needle.
(22)
(23)
(24) A tubular section 7 extends from the actuating surface 3, and the tubular section 7 has in internal helical thread 71 representing an engagement device for engaging a complementary engagement device of the engagement section 11 of the piston rod 10. Thus, the cavity 6 is formed in the interface between the terminal site 13 of the engagement section 11 of the piston rod 10 and the deformable sealing element 5 when the piston rod 10 is inserted into the tubular section 7. Specifically, the complementary engagement device is an external helical thread 14. The internal helical thread 71 defines has a minimum diameter and a maximum diameter defined by the helix. The minimum diameter of the helix will, in this embodiment, be the access diameter defined by the stopper body 2.
(25) The piston rod 10 will normally be made from a hard polymeric material. The piston rods 10, as depicted, have a ridge 12, which has a larger diameter than the largest diameter of the helix of the internal helical thread 71, but smaller than the inner diameter of the cylinder 22. Thereby, the ridge 12 defines how deep into the tubular section 7 the engagement section 11 of the piston rod 10 can be inserted. When the engagement section 11 of the piston rod 10 has been fully inserted into the tubular section 7, i.e. in the embodiments shown the engagement section 11 is screwed into the tubular section 7, a cavity 6 is formed between the terminal site 13 of the piston rod 10. The cavity 6 may thus be a cylindrical cavity 6 as shown in
(26)
(27)
(28)
(29)
(30)
(31)
(32) A further embodiment of the stopper 1 of the invention is shown in
EXAMPLES
Example 1
(33) The stopper depicted in
(34) TABLE-US-00002 TABLE 2 BLF test results for 1 ml injector, 2- deformable sealing elements stopper. Test conditions Number of Glide force, N 23° C., 50% RH replicates Average BLF (N) 2-30 mm WFI 4 10 (1) 5.2 (1.9) Tween solution 4 9.2 (0.7) 3.7 (0.7)
(35) For comparison stoppers were prepared having only a single deformable sealing element and the tests were repeated. The results are shown in Table 3.
(36) TABLE-US-00003 TABLE 3 BLF test results for 1 ml injector, 1-deformable sealing element stopper. Test conditions Number of Glide force, N 23° C., 50% RH replicates Average BLF (N) 2-30 mm WFI 4 6.2 (0.2) 2.1 (0.4) Tween solution 4 5.0 (0.2) 1.6 (0.7)
(37) In Table 2 and Table 3, the numbers in brackets represent the standard deviations. Glide force gives the average forces for displacements between 2 mm and 30 mm. The average and standard deviation are computed for all data curves combined.
(38) Thus, the stopper of the invention provided consistently low BLF values and also low glide force.
(39) The same stoppers and glass injectors, i.e. stoppers having 1 deformable sealing element and stoppers having 2 deformable sealing elements, were also tested for Cylinder closure integrity (CCI). Specifically, the injectors were prefilled with blue dye solution prepared according to the guidelines in ASTM F 1929, and the tests were based on Pharmaceutical Package Integrity, Parenteral Drug Association's Technical Report No. 27, 1998. The injectors were laid on absorbent paper in a desiccator with the vacuum profile shown in Table 4 and Table 5.
(40) TABLE-US-00004 TABLE 4 CCI test results for 1 ml injector, 1-deformable sealing element stopper Inspection Inspection Inspection after −25 mbar, after −35 mbar, after −100 mbar, 10 min 10 min 10 min No leaking No leaking No leaking
(41) TABLE-US-00005 TABLE 5 CCI test results for 1 ml injector, 2-deformable sealing element stopper Inspection Inspection Inspection after −25 mbar, after −35 mbar, after −100 mbar, 10 min 10 min 10 min No leaking No leaking No leaking
(42) No leaking indicates that the injection system can contain the dye during the vacuum challenges. Thus, the stoppers of the invention provide injectors complying with CCI requirements, also when the stopper has only a single deformable sealing element.
Example 2
(43) Further experiments were conducted with the 1 ml injectors with either the one or two deformable sealing element stoppers to test the CCI and BLF over a period of time of up to 4 weeks. In contrast to Example 1, the injectors had cylinders of cyclic olefin polymer (COP). The injectors with the integrated needle were pre-filled with solutions of 0.10% surfactant (Tween80) in water and stored at 23° C., 50% relative humidity (RH) until testing began.
(44) The area around the stopper was observed immediately after filling the injectors and after 1 hour, 1 week, 2 weeks and 4 weeks. No leakage was observed for any specimen and it was concluded that the injectors comply with CCI requirements.
(45) For the measurements of BLF values, the injectors were tested with a stroke speed of 100 mm/min over 28 mm. The BLF values are shown in Table 6.
(46) TABLE-US-00006 TABLE 6 BLF values over time Immediately 1 week after 2 weeks after 4 weeks after Specimen after filling filling filling filling 1 deformable 9.9 10.8 9.4 10.0 sealing element 2 deformable 12.7 14.6 13.7 13.5 sealing elements
(47) Thus, no significant development in BLF values was observed over a period of 4 weeks, which shows that the stopper of the invention is suited for use in a pre-filled injector. In all cases the BLF values were within an acceptable range.
REFERENCE NUMERALS
(48) 1001 Prior art stopper 1002 Piston body of prior art stopper 1003 Actuating end of prior art stopper 1004 Outlet end of prior art stopper 1005 Sealing element of prior art stopper 1006 Solid section of prior art stopper 1007 Tubular section of prior art stopper 1008 Internal helical thread of prior art stopper 1 Stopper of the invention 2 Stopper body 3 Actuating surface 4 Outlet surface 5 Deformable sealing element 51 Supporting sealing element 6 Cavity 7 Tubular section 71 Internal helical thread 72 Protrusion 81 Actuating stopper element 82 Outlet stopper element 83 Resilient frame 84 Compressible section 10 Piston rod 11 Engagement section 12 Ridge 13 Terminal site of piston rod 14 External helical thread 21 Injector 22 Cylinder 23 Inner wall of the cylinder